Expert Perspective: Immune Checkpoint Inhibitors and Rheumatologic Complications

Immune checkpoint inhibitors can cause inflammatory syndromes known as immune‐related adverse events (IRAEs). Several rheumatic IRAEs have been reported, and this article discusses the approach to their management, including examination and testing, and drug treatment.

Source:

Arthritis & Rheumatology